| ||||||||||||||||||||
Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Agonist Antibody Files in this Data Supplement:
J. Natl. Cancer Inst. Shanker et al.
100: 649
Supplementary Data
| ||||||||||||||||||||
| ||||||||||||||||||||
Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Agonist Antibody Files in this Data Supplement:
J. Natl. Cancer Inst. Shanker et al.
100: 649
Supplementary Data
| ||||||||||||||||||||